跳至主要内容
临床试验/NL-OMON50316
NL-OMON50316尚未招募不适用

Randomized controlled trial to assess the effect of vitamin K supplementation on the rate of elastin degradation in COPD - Vitamin K in COPD

CIRO0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Written informed consent
  • - Diagnosed with COPD based on post-bronchodilator FEV1/GVC <0.70 accordig to
  • the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.
  • -Ability to comply with all study requirements
  • - Age >40 years

排除标准

  • - Pregnant or lactating women, or subjects who intend to become pregnant within
  • the study period
  • -Subjects using vitamin K1 or K2 as supplements
  • -Active malignancy or cured malignancy <12 months prior to enrollment
  • -Use of vitamin K antagonists (acenocoumarol, fenprocoumon) in 12 months prior
  • to inclusion
  • - expectation of impaired gastro-intestinal uptake of vitamin K such as history
  • of (partial)bowel resection
  • -Serious mental impairment
  • -Exacerbation <2 weeks prior to enrolment
  • -Life expectation of less than 6 months on the basis of concurrent disease

研究者

发起方
CIRO

相似试验

Randomized controlled trial to assess the effect of... | 临床试验